• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过限制巨噬细胞和血管壁细胞中超氧化物的产生,动脉粥样硬化会得到缓解。

Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells.

作者信息

Vendrov Aleksandr E, Hakim Zeenat S, Madamanchi Nageswara R, Rojas Mauricio, Madamanchi Chaitanya, Runge Marschall S

机构信息

Department of Medicine, University of North Carolina at Chapel Hill, 3033 Old Clinic Building, Chapel Hill, NC 27599-7005, USA.

出版信息

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2714-21. doi: 10.1161/ATVBAHA.107.152629. Epub 2007 Sep 6.

DOI:10.1161/ATVBAHA.107.152629
PMID:17823367
Abstract

OBJECTIVE

We previously showed that NAD(P)H oxidase deficiency significantly reduces atherosclerosis in apoE(-/-) mice. The present study was designed to determine the relative contribution of monocyte/macrophage versus vascular wall cell NAD(P)H oxidase to atherogenesis in this model.

METHODS AND RESULTS

Cell-specific NAD(P)H oxidase inhibition was achieved via allogenic, sex-mismatched bone marrow transplantation. Aortic atherosclerosis and superoxide production in apoE(-/-) mice (Control) with functional NAD(P)H oxidase in both monocytes/macrophages and vascular wall cells was compared with that in apoE(-/-) mice with nonfunctional monocyte/macrophage NAD(P)H oxidase (BMO) or nonfunctional vessel wall NAD(P)H oxidase (VWO). A significant decrease in superoxide production and atherosclerotic lesions was observed in BMO and VWO mice compared with control mice. Interestingly, BMO mice had significantly lower plasma oxidized LDL levels compared with control and VWO mice, whereas aortic sections of VWO mice showed decreased expression of cellular adhesion molecules compared with control and BMO mice. NAD(P)H oxidase deficiency also attenuated neointimal hyperplasia and mitogenic protein activation in apoE(-/-) mice after arterial injury.

CONCLUSIONS

We conclude that (1) both monocyte/macrophages and vessel wall cells play critical roles in atherogenesis; (2) decrease in atherosclerosis results from attenuated superoxide generation in monocyte/macrophages or vessel wall cells; and (3) superoxide generation may impact atherosclerosis, in part, by activating smooth muscle cell mitogenic signaling pathways.

摘要

目的

我们之前的研究表明,NAD(P)H氧化酶缺乏可显著减轻载脂蛋白E基因敲除(apoE(-/-))小鼠的动脉粥样硬化。本研究旨在确定在该模型中,单核细胞/巨噬细胞与血管壁细胞NAD(P)H氧化酶对动脉粥样硬化发生的相对作用。

方法与结果

通过同种异体、性别不匹配的骨髓移植实现细胞特异性NAD(P)H氧化酶抑制。将单核细胞/巨噬细胞和血管壁细胞中具有功能性NAD(P)H氧化酶的apoE(-/-)小鼠(对照组)的主动脉粥样硬化和超氧化物生成情况,与单核细胞/巨噬细胞NAD(P)H氧化酶无功能的apoE(-/-)小鼠(BMO组)或血管壁NAD(P)H氧化酶无功能的apoE(-/-)小鼠(VWO组)进行比较。与对照组小鼠相比,BMO组和VWO组小鼠的超氧化物生成和动脉粥样硬化病变显著减少。有趣的是,与对照组和VWO组小鼠相比,BMO组小鼠的血浆氧化型低密度脂蛋白水平显著降低,而与对照组和BMO组小鼠相比,VWO组小鼠的主动脉切片显示细胞黏附分子表达减少。NAD(P)H氧化酶缺乏还可减轻apoE(-/-)小鼠动脉损伤后的内膜增生和有丝分裂原蛋白激活。

结论

我们得出以下结论:(1)单核细胞/巨噬细胞和血管壁细胞在动脉粥样硬化发生中均起关键作用;(2)动脉粥样硬化的减轻是由于单核细胞/巨噬细胞或血管壁细胞中超氧化物生成减少;(3)超氧化物生成可能部分通过激活平滑肌细胞有丝分裂信号通路影响动脉粥样硬化。

相似文献

1
Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells.通过限制巨噬细胞和血管壁细胞中超氧化物的产生,动脉粥样硬化会得到缓解。
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2714-21. doi: 10.1161/ATVBAHA.107.152629. Epub 2007 Sep 6.
2
Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice.右美沙芬可减轻小鼠的氧化应激反应,并抑制动脉粥样硬化和新生内膜形成。
Cardiovasc Res. 2009 Apr 1;82(1):161-9. doi: 10.1093/cvr/cvp043. Epub 2009 Feb 3.
3
Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.血管紧张素转换酶 2 的缺失促进动脉粥样硬化和动脉新生内膜形成。
Cardiovasc Res. 2014 Feb 1;101(2):236-46. doi: 10.1093/cvr/cvt245. Epub 2013 Nov 4.
4
IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.胰岛素样生长因子-1可减轻载脂蛋白E缺陷小鼠的炎症反应,抑制氧化应激,并减缓动脉粥样硬化进程。
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2684-90. doi: 10.1161/ATVBAHA.107.156257. Epub 2007 Oct 4.
5
Thrombin and NAD(P)H oxidase-mediated regulation of CD44 and BMP4-Id pathway in VSMC, restenosis, and atherosclerosis.凝血酶和NAD(P)H氧化酶介导的血管平滑肌细胞中CD44和BMP4-Id信号通路调控、再狭窄及动脉粥样硬化
Circ Res. 2006 May 26;98(10):1254-63. doi: 10.1161/01.RES.0000221214.37803.79. Epub 2006 Apr 6.
6
Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways.内毒素通过激活NADPH氧化酶和丝裂原活化蛋白激酶信号通路诱导血管平滑肌细胞中Toll样受体4的表达。
Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2630-7. doi: 10.1161/01.ATV.0000247259.01257.b3. Epub 2006 Sep 28.
7
Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.P2Y1/载脂蛋白E双敲除小鼠动脉粥样硬化病变减少:非造血源性P2Y1受体的作用
Circulation. 2008 Aug 12;118(7):754-63. doi: 10.1161/CIRCULATIONAHA.108.788927. Epub 2008 Jul 28.
8
The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation.清道夫受体CD36在调节单核吞噬细胞向动脉粥样硬化病变部位的迁移及血管炎症中的作用。
Cardiovasc Res. 2009 Jul 1;83(1):42-51. doi: 10.1093/cvr/cvp081. Epub 2009 Mar 5.
9
Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.组氨酸 H1 受体通过增加低密度脂蛋白的血管通透性促进动脉粥样硬化病变形成。
Arterioscler Thromb Vasc Biol. 2010 May;30(5):923-30. doi: 10.1161/ATVBAHA.109.201079. Epub 2010 Mar 4.
10
Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.内皮细胞衍生的血管生成素样蛋白 2 在血管炎症导致内皮功能障碍和动脉粥样硬化进展中的作用。
Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):790-800. doi: 10.1161/ATVBAHA.113.303116. Epub 2014 Feb 13.

引用本文的文献

1
A TRPM2-Driven Signalling Cycle Orchestrates Abnormal Inter-Organelle Crosstalk in Cardiovascular and Metabolic Diseases.TRPM2驱动的信号转导循环在心血管和代谢疾病中协调异常的细胞器间串扰。
Biomolecules. 2025 Aug 19;15(8):1193. doi: 10.3390/biom15081193.
2
snoRNAs Downregulate Smooth Muscle Cell COX4I2 and Promote Neointimal Hyperplasia.小核仁RNA下调平滑肌细胞中的COX4I2并促进内膜增生。
bioRxiv. 2025 Jul 27:2025.07.23.666475. doi: 10.1101/2025.07.23.666475.
3
Inter-Organelle Crosstalk in Oxidative Distress: A Unified TRPM2-NOX2 Mediated Vicious Cycle Involving Ca, Zn, and ROS Amplification.
氧化应激中的细胞器间串扰:由TRPM2-NOX2介导的涉及钙、锌和活性氧放大的统一恶性循环
Antioxidants (Basel). 2025 Jun 24;14(7):776. doi: 10.3390/antiox14070776.
4
Mitigating Vascular Inflammation by Mimicking AIBP Mechanisms: A New Therapeutic End for Atherosclerotic Cardiovascular Disease.通过模拟 AIBP 机制减轻血管炎症:动脉粥样硬化性心血管疾病的新治疗靶点。
Int J Mol Sci. 2024 Sep 25;25(19):10314. doi: 10.3390/ijms251910314.
5
Delineating the NOX-Mediated Promising Therapeutic Strategies for the Management of Various Cardiovascular Disorders: A Comprehensive Review.描绘用于管理各种心血管疾病的NOX介导的有前景的治疗策略:一项综述
Curr Vasc Pharmacol. 2025;23(1):12-30. doi: 10.2174/0115701611308870240910115023.
6
Endothelial Reprogramming in Atherosclerosis.动脉粥样硬化中的内皮细胞重编程
Bioengineering (Basel). 2024 Mar 27;11(4):325. doi: 10.3390/bioengineering11040325.
7
Macrophage immunometabolism in diabetes-associated atherosclerosis.糖尿病相关性动脉粥样硬化中的巨噬细胞免疫代谢
Immunometabolism (Cobham). 2023 Oct 16;5(4):e00032. doi: 10.1097/IN9.0000000000000032. eCollection 2023 Oct.
8
Olive mill wastewater and hydroxytyrosol inhibits atherogenesis in apolipoprotein E-deficient mice.橄榄油厂废水和羟基酪醇可抑制载脂蛋白 E 缺陷小鼠的动脉粥样硬化形成。
Heart Vessels. 2023 Nov;38(11):1386-1394. doi: 10.1007/s00380-023-02290-5. Epub 2023 Jul 18.
9
Antioxidant Properties of Oral Antithrombotic Therapies in Atherosclerotic Disease and Atrial Fibrillation.口服抗血栓治疗在动脉粥样硬化疾病和心房颤动中的抗氧化特性
Antioxidants (Basel). 2023 May 30;12(6):1185. doi: 10.3390/antiox12061185.
10
Radical oxygen species: an important breakthrough point for botanical drugs to regulate oxidative stress and treat the disorder of glycolipid metabolism.活性氧:植物药调节氧化应激和治疗糖脂代谢紊乱的重要突破点。
Front Pharmacol. 2023 May 12;14:1166178. doi: 10.3389/fphar.2023.1166178. eCollection 2023.